Moneycontrol PRO
HomeNewsBusinessFM Nirmala Sitharaman promises 'never before' like Union Budget

FM Nirmala Sitharaman promises 'never before' like Union Budget

The Union Budget for 2021-22 is scheduled to be presented in Parliament on February 1, 2021.

December 18, 2020 / 21:06 IST
Finance Minister Nirmala Sitharaman.

Finance Minister Nirmala Sitharaman on December 18 promised a "never before" like Union Budget as the government looks to steer the pandemic-battered economy and push growth. While investment in health, medical Research & Development (R&D) and developing greater skills to handle telemedicine is going to be critical, livelihood challenges would have to be seen in a newer canvas with newer perspective on vocational training and skill development.

"Send me your inputs so that we can see a Budget which is a Budget like never before, in a way. 100 years of India wouldn't have seen a Budget being made post pandemic like this. "And that is not going to be possible unless I get your inputs and wish list, clear observation of what has put you through the challenge… Without that, it is impossible for me to draft something which is going to be that Budget like never before, a Budget which is being made after a pandemic," Sitharaman said while addressing the CII Partnership Summit 2020.

The Union Budget for 2021-22 is scheduled to be presented in Parliament on February 1, 2021. The minister said that to revive growth, support has to be extended to those areas which have been disrupted badly due to the COVID-19 pandemic as well as to those areas which are now going to be the centres for newer demand and newer engines of growth.

"Considering our size, population and potential that India hold for good growth and building of economy, I wouldn't hesitate here to say that we shall be the engine of global growth along with a few other countries. We will be a significant contributor to global economic revival," she said. Further, Sitharaman said that while providing more funding for infrastructure, it would be important to bring in private partnerships for not just providing buildings and hospitals, but also for providing the capacities to run these hospitals.

Telemedicines will also need greater level of understanding and greater skills to handle, she noted. "… many economies are wondering where to procure the vaccine from after they are formulated or after they are certified, those which are getting manufactured somewhere, will have to be obtained. "

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"Whereas we in India are actually very fortunate to have such capacities to produce the formulation, then to get it certified and we in India have the capacity to be able to produce as much as we (need)… and more for exports…," she said. Sitharaman also said that the need of the time is more investments towards medical R&D, biotechnology R&D and pharma R&D. India has to look at both public and private partnership and also engagement and investment in the areas of research for medicine, she added.

"We will probably be taking all the inputs that health sector has given us for a good consideration in the Budget," the minister said. "A good example of Aatmanirbhar Bharat is the capacity that we have shown to produce vaccines, to manufacture formulations that the vaccine developers have given and be in a position not just to manufacture those vaccines which we are formulating in India but also to receive the rights to produce vaccines which are developed elsewhere not just for Indian markets but also to export," she said.

According to the minister, job creation would undergo massive change post pandemic and hence newer skills would have to be imparted. "Livelihood is also going to be a newer canvas in the post pandemic era. Whether it is small businesses or large industries, the way in which jobs are going to be created will go through a massive change… So vocational training and skills have to be brought in with newer perspective, some of the trainings and skills given earlier may probably be not even required now but something totally new may be required," she said.

Livelihood is going to be a basketful of challenges where industry would have to put in their views, she added.

Follow our full coverage of the coronavirus pandemic here.

PTI
first published: Dec 18, 2020 09:06 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347